From: A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models
Key resources table: MSA cases
Patient designation
Neurological diagnosis
Primary pathological diagnosis
Secondary pathological diagnosis
Thal
Braak
CERAD
Age
Sex
MSA-1
MSA-P
MSA
PART
0
II
none
77
M
MSA-2
MSA-C
AD low; CAA
3
I
sparse
71